ENERGENESIS BIOMEDICAL CO., LTD.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Based on its ENERGI platform, the company is developing multiple novel therapeutics including ENERGI‑F705PD (an oral therapy for Parkinson’s disease) and ENERGI‑F703DFU (a gel for diabetic foot ulcers), committed to leveraging boosted cellular ATP and ant
Founded Year
2012
Unified Business No.
53726093
Status
Active
Number of Employees
20
Total Paid-in
Capital
888,080,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Listing(2023)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Energenesis Biomedical Co., Ltd., founded in 2012 and recognized as a biopharmaceutical company in 2015, leverages its proprietary ENERGI platform to enhance cellular energy and activate self‑repair mechanisms, aiming to become a rising star in Taiwan’s biotech industry.
